Literature DB >> 19072686

New uracil dimers showing erythroid differentiation inducing activities.

Alessandro Accetta1, Roberto Corradini, Stefano Sforza, Tullia Tedeschi, Eleonora Brognara, Monica Borgatti, Roberto Gambari, Rosangela Marchelli.   

Abstract

The synthesis of C5 linked uracil dimers was carried out according to a model developed in order to bind adenine in DNA. N1-Alkylated uracil derivatives were synthesized from isoorotic acid (uracil-5-carboxylic acid) or thymine. The carboxylic acid derivatives were condensed with diamines in order to produce dimeric compounds or with monoamines in order to obtain reference monomeric compounds. Some of the derivatives, in particular the uracil dimers, showed antiproliferative and erythroid differentiation induction properties towards human chronic myelogenous leukemia K562 cells, thus indicating that these compounds could represent a new class of drugs useful for the development of antitumor therapy based on the ability to induce terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072686     DOI: 10.1021/jm800982q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Synthesis and EPR studies of 2'-deoxyuridines with alkynyl, rodlike linkages.

Authors:  Adam Sniady; Michael D Sevilla; Srinivasarao Meneni; Tadeusz Lis; Slawomir Szafert; Deepthi Khanduri; John M Finke; Roman Dembinski
Journal:  Chemistry       Date:  2009-08-03       Impact factor: 5.236

2.  Symmetrical and unsymmetrical alpha,omega-nucleobase amide-conjugated systems.

Authors:  Sławomir Boncel; Maciej Maczka; Krzysztof K K Koziol; Radosław Motyka; Krzysztof Z Walczak
Journal:  Beilstein J Org Chem       Date:  2010-04-12       Impact factor: 2.883

3.  C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.

Authors:  Eleonora Brognara; Ilaria Lampronti; Giulia Breveglieri; Alessandro Accetta; Roberto Corradini; Alex Manicardi; Monica Borgatti; Alessandro Canella; Chiara Multineddu; Rosangela Marchelli; Roberto Gambari
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.